If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.30    0.00 (0.00%)
Bid:
0.29
Ask:
0.31
Spread: 0.02 (6.897%)
Market Cap: £17.39m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Holding(s) in Company

2 Apr 2012 16:39

RNS Number : 6522A
CAP-XX Limited
02 April 2012
 



 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CAP-XX Ltd

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Change to the ISC

X

3. Full name of person(s) subject to thenotification obligation: iii

Henderson Global Investors

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30 March 2012

6. Date on which issuer notified:

02 April 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

Crossed below 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBPNPV

7,781,575

7,781,575

7,781,575

9.01%

AU0000XINAS1

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,781,575

9.01%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Wayne Powell

15. Contact telephone number:

020 7818 5611

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLELLFBLZFXBBV
Date   Source Headline
24th Jan 20177:00 amRNSSubscription to raise £2.43 million
5th Jan 201711:40 amRNSMurata Product Launch
8th Dec 20167:00 amRNSIssue of Shares and Director/PDMR Shareholdings
8th Dec 20167:00 amRNSHolding(s) in Company
7th Dec 20169:01 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSLower cost for automotive supercapacitor units
29th Nov 20167:22 amRNSResult of AGM and Chairman's AGM statement
22nd Nov 20167:00 amRNSCap-XX awarded SAE-A's 2016 Platinum Award
10th Nov 20167:00 amRNSNotice of AGM
31st Oct 20167:00 amRNSTax Rebate
26th Oct 20168:57 amRNSHolding(s) in Company
4th Oct 20167:00 amRNSAudited results for the year ended 30 June 2016
26th Sep 201611:00 amRNSAVX supercapacitor launch
13th Sep 20169:00 amRNSNotice of Results
12th Jul 20167:00 amRNS£1 million AVX licence received
29th Jun 20167:00 amRNSProduct launch by Murata
22nd Jun 20167:00 amRNSNew customer orders: Automotive evaluation units
5th May 20167:00 amRNSIssue of Shares
30th Mar 20161:02 pmRNSReplacement Interim Results for HY ended 31 Dec'15
30th Mar 20167:00 amRNSInterim Results for the half-year ended 31.12.2015
29th Mar 201611:21 amRNSHolding(s) in Company
22nd Mar 20167:00 amRNSAVX technology licence agreement
8th Mar 201610:00 amRNSNotice of Results
15th Feb 20167:00 amRNSCAP-XX automotive MoU extended & Thinline progress
21st Dec 201511:00 amRNSLong life supercapacitor R&D programme
15th Dec 20157:00 amRNSInvestor Presentations
8th Dec 201510:28 amRNSIssue of Shares and Granting of Share Options
12th Nov 20159:00 amRNSInvestor Presentations
12th Oct 20159:33 amRNSResult of AGM and Chairman's AGM statement
4th Sep 201511:10 amRNSNotice of AGM and Publication of Report & Accounts
1st Sep 20157:03 amRNSAudited Results for the year ended 30 June 2015
21st Jul 20153:25 pmRNSTrading update and notice of results
7th Jul 20152:30 pmRNSThinline receives prestigious Electron d'Or Award
22nd Jun 201511:00 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSCAP-XX ships Thinline supercapacitors
2nd Jun 201512:38 pmRNSDirectors' Dealings and Issue of Equity
1st Jun 20157:00 amRNSCAP-XX secures order under automotive MoU
15th May 20154:48 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
11th May 20157:00 amRNSPlacing to raise £1.0 million
5th May 201510:55 amRNSProposed Placing
1st May 20159:25 amRNSNotification of Major Interest in Shares
1st May 20159:24 amRNSNotification of Major Interest in Shares
29th Apr 201510:31 amRNSCAP-XX releases world's thinnest supercapacitors
21st Apr 201512:17 pmRNSNotification of Major Interest in Shares
20th Apr 20157:20 amRNSHolding(s) in Company
20th Apr 20157:15 amRNSHolding(s) in Company
15th Apr 20157:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Apr 201510:05 amRNSAppointment of Nominated Adviser and Sole Broker
9th Apr 201511:30 amRNSResult of General Meeting
8th Apr 20157:00 amRNSCAP-XX-THALES Feasibility Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.